| |
 |
ADVANCED
HEALTHCARE TECHNOLOGIES, INC. (OTCBB: AVHC) |
 |
Dear Reader,
Today's feature company, Advanced Healthcare Technologies
Inc. (OTCBB: AVHC), has breaking news released toward the
end of today's trading.
The news involves a new study of AVHC's FDA cleared, wound treatment
technology. The study is designed to measure oxygen levels
at the patient's wound site in order to demonstrate that topical
hyperbaric treatment delivered by AVHC's product increases oxygen
levels at the wound site, eliminating the need, expense and possible
risk of full body oxygen chamber treatment. Early results
already reported with the initial patient are very encouraging
and quite dramatic as you will see.
Excerpt from today's news:
The initial patient being treated has a pressure ulcer
which has been open for FOUR YEARS and has been treated with numerous
forms of wound therapy, all of which have failed. In just 7 treatments
(one week) with AHT's FDA cleared rigid extremity chamber the
wound has decreased by 25%. Based upon this initial result, it
is anticipated that the wound will be completely healed within
4 to 6 weeks!
"We are optimistic that the study will document the
results that we have been witnessing with this first patient and
will support our belief that topical hyperbaric treatment is the
safest and most efficient means of delivering this limb and life
saving treatment," stated AVHC President, Phillip Loori.
AVHC is an ongoing feature for StockUpTicks (click
here for our November 22 in-depth profile) and we strongly encourage
you to read the news release (below) as this compelling story
continues to develop.
|
****
TODAY'S NEWS FROM AVHC **** |
|
Press Release
Source: Advanced Healthcare Technologies, Inc.
Advanced Hyperbaric Technologies, Inc.,
a Subsidiary of Advanced Healthcare
Technologies, Inc., Announces the Commencement
of a New Topical
Hyperbaric Treatment Study Utilizing Its, FDA
Cleared, Rigid Extremity Chamber
Wednesday January 22, 2:22 pm ET
FARMINGDALE, N.J., Jan. 22 /PRNewswire-FirstCall/ -- Advanced
Hyperbaric Technologies, Inc., a subsidiary of Advanced Healthcare
Technologies, Inc. (OTC Bulletin Board: AVHC - News) today announces
the commencement of a new topical hyperbaric treatment study utilizing
its, FDA cleared, rigid extremity chamber.
New Topical Hyperbaric Oxygen Study In its continuing effort
to document the benefits of topical hyperbaric oxygen treatment
of wounds, Advanced Hyperbaric Technologies (AHT) has commenced
the first in a series of planned studies of topical hyperbaric
oxygen treatment on a variety of wound patients. The latest study
is being conducted at Northeast Center for Special Care, a 275
bed traumatic brain and spinal cord injury rehabilitation center,
by Dr. Bok Lee, a leading wound care specialist. The study will
utilize a specialized oxygen measurement device called an Oximeter.
The purpose is to demonstrate that topical hyperbaric treatment
delivered by the FDA cleared rigid extremity chamber manufactured
by AHT actually increases the oxygen levels at the wound site,
thereby eliminating the need, expense and possible risk of full
body oxygen chamber treatment.
The initial patient being treated has a pressure ulcer which
has been open for FOUR YEARS and has been treated with numerous
forms of wound therapy, all of which have failed. In just 7 treatments
(one week) with AHT's FDA cleared rigid extremity chamber the
wound has decreased by 25%. Based upon this initial result, it
is anticipated that the wound will be completely healed within
4 to 6 weeks!
"We are optimistic that the study will document the results that
we have been witnessing with this first patient and will support
our belief that topical hyperbaric treatment is the safest and
most efficient means of delivering this limb and life saving treatment,"
stated President Phillip Loori.
About Advanced Healthcare Technologies
Advanced Healthcare Technologies, Inc. is a company engaged in
the acquisition and incubation of niche and proprietary technologies/companies
in the healthcare industry.
About Advanced Hyperbaric Technologies
Advanced Hyperbaric Technologies, Inc. is a company engaged in
the manufacture and sale of Topical Hyperbaric Oxygen Chambers
and Sacral Units for the healing of open wounds. The chambers
are marketed to hospitals, doctors, wound care clinics, nursing
homes, and patients.
For further information, visit the Advanced Healthcare Technologies,
Inc. web site at www.advancedhealthcaretechnologies.com and visit
the Advanced Hyperbaric Technologies web site at www.advanced-hyperbaric.com,
or contact Advanced Healthcare Technologies at 800-327-4325.
Please contact Pacifica Financial Group, 949-852-1812 for further
information.
Statements regarding financial matters in this press release
other than historical facts are "forward-looking statements" within
the meaning of section 27A of the Securities Act of 1933, Section
21E of the Securities Exchange Act of 1934, and as that term is
defined in the Private Securities Litigation Reform Act of 1995.
The company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all
other forward-looking statements be subject to the safe harbors
created thereby. Since these statements (future operational results
and sales) involve risks and uncertainties and are subject to
change at any time, the Company's actual results may differ materially
from expected results.
Source: Advanced Healthcare Technologies, Inc.
|
****
ABOUT AVHC **** |
|
 |
Advanced Healthcare Technologies is a company that
engages in the acquisition of leading technologies in the
healthcare industry. Principle acquisition targets consist
of companies in the Medical Device and Medical Service Industry.
Recent Acquisitions include: Advanced Hyperbaric Technologies
(AHT) of Farmingdale, NJ. Advanced Hyperbaric engages
in the sale of Topical Hyperbaric Oxygen Chambers for
the healing of open wounds. Its products are used to treat
patients who suffer from chronic open wounds due to diabetes,
vascular insufficiencies, post surgical infections, amputations,
frostbite and burns. The chambers are marketed to hospitals,
doctors, wound care clinics, nursing homes, and patients.
AHT's principle products include a portable topical Hyperbaric
Oxygen chamber and a Disposable Sacral Topical Hyperbaric
Oxygen System for smaller wounds.
|
|
****
CONTACT **** |
|
Advanced Healthcare Technologies
124 Colts Neck Road
Farmingdale, NJ 07727
Company Contact: Phillip Loori
Tel: 800-327-4325
Email: philliploori@aol.com
Brokers and Analysts: Guy Vinci, Tel: 866-730-9604
Visit the Advanced Healthcare Technologies, Inc. Web site at:
www.advancedhealthcaretechnologies.com
Visit the Advanced Hyperbaric Technologies Web site at: www.advanced-hyperbaric.com
To review the SEC filings for AVHC, Click
Here
Want
to feature YOUR company to over 1 MILLION investors?
Click
here to
learn more about our programs or email us directly at info@stockupticks.com
Stockupticks
Safe Harbor Statement: Statements contained in this document,
including those pertaining to estimates and related plans, potential
mergers and acquisitions, estimates, growth, establishing new markets,
expansion into new markets and related plans other than statements
of historical fact, are forward-looking statements subject to a
number of uncertainties that could cause actual results to differ
materially from statements made. StockUpTicks.com is a property
of Market Pathways Financial Relations Incorporated (MP).
MP provides no assurance as to the subject company's plans or ability
to effect any planned and/or proposed actions. MP has no first-hand
knowledge of management and therefore cannot comment on its capabilities,
intent, resources, nor experience and makes no attempt to do so.
Statistical information, dollar amounts, and market size data was
provided by the subject company and related sources believed by
MP to be reliable, but MP provides no assurance, and none is given,
as to the accuracy and completeness of this information.
Disclaimer:
StockUpTicks.com is a property of Market Pathways Financial Relations
Incorporated (MP). The information, opinions and analysis
contained herein are based on sources believed to be reliable
but no representation, expressed or implied, is made as to its
accuracy, completeness or correctness. Past performance
is no guarantee of future results. This report is a paid advertisement
and is for information purposes only and should not be used as
the basis for any investment decision. MP
has been compensated with 192,000 shares of common stock of Advanced
Healthcare Technologies, Inc., by ARB Consulting, Inc., for preparation
and distribution of this report and other advertising services.
This constitutes a conflict of interest as to MP’s ability
to remain objective in its communication regarding the subject
company. Write or call MP for detailed disclosure as required
by Rule 17b of the Securities Act of 1933/1934. MP is not
an investment advisor and this report is not investment advice.
This information is neither a solicitation to buy nor an offer
to sell securities but is a paid advertisement. Information
contained herein contains forward-looking statements and is subject
to significant risks and uncertainties, which will affect the
results. The opinions contained herein reflect our current
judgment and are subject to change without notice. MP and/or its
affiliates, associates and employees from time to time may have
either a long or short position in securities mentioned.
Information contained herein may not be reproduced in whole or
in part without the express written consent of Market Pathways
Financial Relations Incorporated.
|
|
